STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION
Monday, February 28, 2011   9:30 AM - 12:00 Noon
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
Title and Authors
Azacitidine Treatment of MDS/AML: Effect on Immunophenotyping by Flow Cytometry and Associated Cytogenetic Findings.
A Torabi, JZ Huang, VK Douglas-Nikitin, MD Smith - William Beaumont Hospital, Royal Oak, MI
Myeloid Neoplasms Secondary to Plasma Cell Myeloma: Clinicopathological Study of 11 Cases.
DM Reddi, EL Boswell, CM Lu, E Wang - Duke University Medical Center, Durham, NC; University of California San Francisco
Myelodysplastic Syndrome with DEL(5q): A Comprehensive Analysis of 24 Cases from One Institution.
S Verma, JT Geyer, S Subramaniyam, S Mathew, R Espinal-Witter, DM Knowles, A Orazi - Weill Cornell Medical College, New York
Degradation of BCL-XL by Activated p38 Pathway Plays a Key Role in Myelodysplastic Syndromes (MDSs) . Revealed by Reverse Phase Protein Array (RPPA) and Computational Mathematical Model.
L Zhang, J Wen, Y Zu, A Ewton, H Peng, X Zhou, C-C Chang - Methodist Hospital & Weill Cornell Medical College, Houston, TX; Methodist Hospital Research Institute, Houston, TX
Integrative Analysis of Next Generation Sequencing for Small Non-Coding RNAs and Transcriptional Regulation in Myelodysplastic Syndromes.
JM Gonzalez-Berjon, D Beck, S Ayers, J Wen, M Brandl, T Pham, P Webb, X Zhou, CC Chang - The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX; The University of New South Wales, Canberra, ACT, Australia; The Methodist Hospital Research Institute, Houston, TX; Weill Cornell Medical College, New York, NY
Short Term Imatinib Therapy Promotes Bone Formation in Patients with Chronic Myelogenous Leukemia (CML) Independent of Cytogenetic Response.
D Hoehn, L Medeiros, C Bueso-Ramos - UT M.D. Anderson Cancer Center, Houston, TX
β-Catenin Expression Is Increased in Imatinib-Resistant Chronic Myelogenous Leukemia.
X Zhang, L Moscinski, WW Bulkeley, B Shah, J Pinilla-Ibarz, L Zhang - University of South Florida College of Medicine, Tampa; Moffitt Cancer Center and Research Center, Tampa, FL
Acquired Cytogenetic Aberrations in Philadelphia Chromosome Negative Cells from Patients with Chronic Myelogenous Leukemia Not Associated with Definitive Myelodysplasia.
WW Bulkeley, B Shah, X Zhang, J Pinilla-Ibarz, L Zhang - University of South Florida College of Medicine, Tampa; Moffitt Cancer Center and Research Center, Tampa, FL
Fibrotic Transformation of Polycythemia Vera & Essential Thrombocythemia Is Biologically Indistinguishable from Primary Myelofibrosis.
NA Sangle, C Teman, S Perkins, A Wilson, D Bahler, J Prchal, ME Salama - University of Utah & ARUP Laboratories, Salt Lake City
Development of Monocytosis in Patients with Primary Myelofibrosis Indicates an Accelerated Phase of the Disease.
R Espinal-Witter, JT Geyer, S Verma, DM Knowles, A Orazi - Weill Cornell Medical Center, New York, NY
Paracortical Population of CD11c+CD8-DC Dendritic Cells in Angioimmunoblastic T-Cell Lymphoma.
S Daniel, V Ghali - St. Lukes Roosevelt Hospital, New York, NY; Beth Israel Medical Center, New York, NY
Primary Mucosal CD30-Positive T-Cell Lymphoproliferative Disorders Have Clinicopathologic Features Similar to Primary Cutaneous Cases.
AP Sciallis, ME Law, DJ Inwards, WR Macon, A Dogan, AL Feldman - Mayo Clinic, Rochester, MN
Opposing Effects of Vitamin D/Vitamin D Receptor and Interferon Regulatory Factor-4 in Anaplastic Large Cell Lymphomas.
S Kip, JC Porcher, JR Cerhan, SM Ansell, A Dogan, AL Feldman - Mayo Clinic, Rochester, MN
Distinct Populations of CD8+/CD57+ Large Granular Lymphocytes Are Associated with T-Cell Monoclonality and Define a Subset of Clinically and Pathologically Significant Patients: A Case-Control Study of 70 Patients with Large Granular Lymphocytic Proliferations.
RS Ohgami, IT Pereira, JL Zehnder, DA Arber - Stanford University Medical Center, CA
Down Regulation of Oct-2 Expression in Non-Secretory Plasma Cell Myeloma Is Associated with Decreased Immunoglobulin Transcription.
S Daniel, X Chen, E Poje, E Hyjek, J Vardiman - University of Chicago, IL; William Beaumont Hospital, Troy, MI; Memorial Medical Center, Springfield, IL
CD5-Negative Mantle Cell Lymphoma, a Potential Diagnostic Pitfall. A Single Institution's Experience in past 5 Years.
X Wu, HS Edmund, VVB Reddy - University of Alabama at Birmingham; Cunningham Pathology, St Vincent's Birmingham, AL
Thyroid Lymphomas Express Similar Immunoglobulin VH Genes.
N Aggarwal, TJ Whitney, JA Kant, SH Swerdlow, DW Bahler - University of Pittsburgh Medical Center, PA; University of Utah, Salt Lake City
A New Biological Model Based on Immunohistochemistry Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma.
AM Perry, PN Meyer, TM Cardesa-Salzmann, LM Smith, L Colomo, AL Guillermo, E Campo, TC Greiner, J Delabie, RD Gascoyne, L Rimsza, ES Jaffe, G Ott, A Rosenwald, RM Braziel, R Tubb, J Cook, L Staudt, J Connors, JM Vose, WC Chan, DD Weisenburger - University of Nebraska Medical Center for the Lymphoma/Leukemia Molecular Profiling Project, Omaha
Inhibition of BCL6 as a Mechanism To Target Therapy-Resistant Malignant Cells.
K Wolniak, N Mohindra, T Lax, L Cerchietti, A Melnick, J Licht - Northwestern University, Chicago, IL; Children's Memorial Hospital, Chicago, IL; Weill Cornell Medical College, New York, NY
Gene and Protein Isoform Expression Analysis of the BCL-6 Associated Transcriptional Corepressor MTA3 in B- lineage Cells.
DV Spencer, CL Foulks, CM Geigerman, PS Akl, AY Lai, PA Wade, DL Jaye, CE Hill - Emory University, Atlanta, GA; NIEHS, Research Triangle Park, NC
Prognostic Value of Fatty Acid Synthase and Spot14 in Diffuse Large B-Cell Lymphoma.
OV Danilova, HM Froehlich, T Hammour, NB Kuemmerle, NB Levy, WB Kinlaw, P Kaur - Dartmouth-Hitchcock Medical Center, Lebanon, NH; Maine Medical Center, Portland; Dartmouth Medical School, Hanover, NH; Norris Cotton Cancer Center, Lebanon, NH
Characterization of B-Cell Lymphoma Unclassifiable with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma: A Ten Year Retrospective Review.
L Edwards, V Bhagirath, E Krakow, C Keng, A Lytwyn, C Ross, L Thebane, E Cheng, M Sur - McMaster University, Hamilton, ON, Canada
Clinical Significance of CMYC Rearrangement in Diffuse Large B-Cell Lymphoma.
GC Caponetti, B Dave, L Smith, P Meyer, M Bast, P Bierman, G Bociek, J Vose, JO Armitage, P Aoun, K Fu, T Greiner, WC Chan, D Weisenburger - University of Nebraska Medical Center, Omaha
MYC Copy Number and Signal Clusters by Colormetric In-Situ Hybridization (CISH) in Diffuse Large B-Cell Lymphoma (DLBCL).
CM Valentino, NA Johnson, PJ Brunhoeber, H Nitta, RD Gascoyne, TM Grogan, LM Rimsza - University of Arizona School of Medicine, Tucson; British Columbia Cancer Agency, Vancouver, Canada; Ventana Medical Systems Inc., Tucson, AZ; McGill University, Montreal, Canada
The p53 Pathway Is Frequently Deregulated in Pediatric Burkitt Lymphoma, but over Expression of MDM2 or HDM4 Is Not a Common Mechanism.
V Leventaki, V Rodic, MS Jahromi, JM Downie, SR Tripp, MG Bayerl, SL Perkins, P Barnette, JD Schiffman, RR Miles - University of Utah, Salt Lake City; ARUP Laboratories, Salt Lake City, UT; Penn State College of Medicine, Hershey, PA
Plasmablastic Differentiation in Low Grade B-Cell Lymphomas: An Unusual Histological Transformation.
D Martinez, L Colomo, M Rozman, A Valera, E Gine, A Lopez-Guillermo, S Martinez, K Warzocha, T Robak, M Czader, E Campo, A Martinez - Hospital Clinic, University of Barcelona, Spain; Hospital Universitari Joan XXIII, Tarragona, Spain; Institute of Hematology, Warsaw, Poland; Medical University of Lodz, Poland; University of Indiana, Indianapolis
Single Nucleotide Polymorphism (SNP) Array Genomic Profiling Identified High Prevalence of Clonal Diversity Associated with Clinical Progress in Chronic Lymphocytic Leukemia.
L Zhang, I Znoyko, SE Self, DJ Wolff - Medical University of South Carolina, Charleston
Expression of CD137 Protein in Select Hematopoietic Tumors: Implications for Anti-CD137 Immunomodulatory Therapy.
MW Anderson, AG Freud, S Zhao, AA Alizadeh, HE Kohrt, R Warnke, R Levy, Y Natkunam - Stanford, Stanford, CA
Downregulation of A20 Tumor Suppressor Gene Product in Classical Hodgkin Lymphomas and Subtypes of Non-Hodgkin Lymphomas.
AM Gabali, F Keyoumarsi, TG Dafydd, K Elenitoba-Johnson, MS Lim - The University of Michigan, Ann Arbor
ALDH1, Carbonic Anhydrase 1, and CD2AP: Novel, Diagnostically Useful Immunohistochemical Markers To Identify Erythroid Precursors in Bone Marrow Biopsies.
MA Rollins-Raval, K Fuhrer, T Marafioti, CG Roth - University of Pittsburgh Medical Center, PA; University College London, United Kingdom
Detection of T Cell Clonality at Diagnosis, in Small Samples and Monitoring of Minimal Residual Disaease (MRD) Using TCR-V Beta Repertoire Analysis.
PR Tembhare, CM Yuan, L Xi, J Janik, J Morris, M Raffeld, M Stetler-Stevenson - Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Center for Cancer Research, National Cancer Institute, Mark O. Hatfield Clinical Research Center, National Institutes of Health, Bethesda, MD